Product Name:tert-butyl 18-[[(2S)-5-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]amino]-18-oxooctadecanoate

IUPAC Name:tert-butyl 17-{[(2S)-1-(tert-butoxy)-4-({2-[2-({[2-(2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}ethoxy)ethyl]carbamoyl}methoxy)ethoxy]ethyl}carbamoyl)-1-oxobutan-2-yl]carbamoyl}heptadecanoate

CAS:1118767-15-9
Molecular Formula:C47H82N4O15
Purity:95%+
Catalog Number:CM590183
Molecular Weight:943.19

Packing Unit Available Stock Price($) Quantity
CM590183-100mg in stock ǙIJ
CM590183-250mg in stock Ōƚƚ
CM590183-1g in stock ŮǪIJ
CM590183-5g in stock IJƈŌ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1118767-15-9
Molecular Formula:C47H82N4O15
Melting Point:-
Smiles Code:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)ON1C(=O)CCC1=O)C(=O)OC(C)(C)C
Density:
Catalog Number:CM590183
Molecular Weight:943.19
Boiling Point:
MDL No:
Storage:

Category Infos

Fatty Acid Modified Side Chains
Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.